ARK Animal Health

ARK Animal Health is a wholly-owned subsidiary of Sorrento Therapeutics, aimed at bringing innovative solutions to the companion animal market. Our primary development project is a single-dose sterile injectable solution of resiniferatoxin. ARK-001 has received FDA CVM MUMS designation for the control of bone cancer pain in dogs.